A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
Completed · Phase 2
Conditions studied: Pulmonary Hypertension
In brief
This is a prospective, randomized, parallel group study to assess the hemodynamic effect of three different dose regimens of a sustained release (SR) tablet of UT-15C in patients with exercise-induced pulmonary hypertension (PH), as measured by the change in peak total pulmonary resistance index (TPRI) during exercise from Baseline to Week 12.
Key facts
- Study ID
- NCT01104870
- Run by
- United Therapeutics
- People needed
- 50
- Starts
- 2010-04-01
- Expected to finish
- 2013-01-01
- Last updated by the study team
- 2016-05-27
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
- University of Arizona — Tucson, Arizona, United States
- University of California Los Angeles Pulmonary Division — Los Angeles, California, United States
- University of California Davis Medical Center — Sacramento, California, United States
- University of Rochester Medical Center, Mary Parkes Center — Rochester, New York, United States
- The Carl and Edyth Lindner Research Center at The Christ Hospital — Cincinnati, Ohio, United States
- University of Cincinnati — Cincinnati, Ohio, United States
- The Ohio State University Medical Center — Columbus, Ohio, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.